Skip to content
2 Minute Read

Addressing the Challenge of Inaccurate and Incomplete EHRs in Clinical Research

Addressing the Challenge of Inaccurate and Incomplete EHRs in Clinical Research

In our previous blog post, “Navigating Medical Records Acquisition in Clinical Trials,” we unpacked our solution for the time consuming process of sourcing patient medical records. In this followup, we’re addressing the challenge of inaccurate and incomplete EHRs in clinical research. Electronic Health Records (EHRs) form the backbone of healthcare data. However, when it comes to clinical research, EHRs often fall short of expectations. This a significant challenge. They are frequently neither accurate nor comprehensive enough. This lack of precision and completeness in EHRs can create obstacles that can have far-reaching implications on the quality and efficiency of clinical trials.

Reconciling scattered records

A patient may see multiple healthcare providers across different institutions, leading to scattered, disconnected records in various EHRs. In addition to this dispersion, individual institutions also deal with internal complexities. Multiple providers within a single institution often contribute to a patient’s record over time, leading to an unwieldy accumulation of data. This often results in records cluttered with outdated diagnoses, resolved conditions, and discontinued medication regimens, making them less valuable for clinical research.

As a consequence, the reconciliation process conducted by the Principal Investigator (PI) becomes vital in the realm of clinical trials. The PI’s task is to comb through these convoluted medical records. PIs must extract only the most relevant, accurate data for their research. Due to the often inconsistent and ambiguous nature of the information found in EHRs, this task is rarely straightforward.

Inconsistent data

The data from the EHR and what eventually ends up in the source documents, and thus the Electronic Data Capture (EDC) system, may differ significantly. Certain medical conditions noted in the EHR might be omitted from the source data. Conversely, some conditions appearing in the source data might not be explicitly listed in the EHR. However, we can often align these conditions with the patient’s broader medical history, and sometimes even ‘map’ them to it.

Best practice for using EHR in clinical research

Subsequently, the most constructive way to view EHRs in the context of clinical research is as a starting point for source data, rather than a definitive resource. This initial input must undergo careful examination, revision, and refinement to produce a final dataset ready for incorporation into the EDC.

Given the current landscape, there’s a growing necessity for solutions that can streamline the process of gleaning accurate, relevant data from EHRs. That’s where CRIO answers the call, introducing a Medical Record API. CRIO not only pulls in a patient’s health history and care support plan nearly instantly, but, as a site-facing application, it lets the PI, confirm, review, and annotate the information before populating the study source records, and hence the EDC.

Final thoughts:

To conclude, the challenge posed by incomplete and inaccurate EHRs is a significant one in clinical research. EHRs should be viewed as a starting point rather than a final resource. Better data management practices and technology can effectively address this challenge. And by doing so, we can improve the efficiency, reliability, and ultimately, the success of clinical trials.

Schedule a demo to explore how CRIO’s Medical Records API simplifies patient electronic health records collection for clinical trials.

Download the full white paper: Health Information & Clinical Research Integration: The Challenge

Read More: Navigating Medical Records Acquisition in Clinical Trials

Read MoreThe Patient Safety Impact of Medical Record Delays in Clinical Trials

by Daenya McDonald Marketing Director
Share this post
You may also find interesting
Explore our Blog
21 cfr compliance update
Running a Site
5 Minute Read -

21 CFR Part 11 Regulation Compliance Update

Compliance Update:  The 21 CFR Part 11 Regulation is a cornerstone of conducting clinical trials in today’s world.  The release of the regulation 1997 established guidelines for the use of electronic records and electronic signatures in FDA-regulated industries and had a significant impact on the pharmaceutical and medical device industries. The FDA began working on...

The Current State of Clinical Trials in Ukraine—A Conversation with Dr. Roman Fishchuk
Running a Site
4 Minute Read -

The Current State of Clinical Trials in Ukraine—A Conversation with Dr. Roman Fishchuk

Meet Dr. Roman Fishchuk, an esteemed otorhinolaryngologist (ENT) whose journey in the healthcare field has been marked by a commitment to providing medical care and innovative treatment options through clinical trials in his native Ukraine. Having graduated from Ivano-Frankivsk National Medical University, Dr. Fishchuk specialized in otolaryngology and completed a Master’s degree at the University...

Geting Ready for Data Migration with CRIO
Running a Site
3 Minute Read -

Transitioning to CRIO? How to Get Your Data Ready for Migration

You have just signed on to use CRIO and you are excited to get started. Even if you are moving primarily from paper, you may have data that you want to migrate into CRIO rather than having to re-enter it. For many of our new clients, they have a wealth of information available in spreadsheets...

Get articles delivered to your inbox, every week